Results 11 to 20 of about 173,248 (277)

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure. [PDF]

open access: yes, 2019
BACKGROUND: Moderate and moderately severe renal impairment are common in patients with heart failure and reduced ejection fraction, but whether beta-blockers are effective is unclear, leading to underuse of life-saving therapy.
Andersson, B   +22 more
core   +8 more sources

The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment [PDF]

open access: yes, 2003
National surveys suggest that treatment of heart failure in daily practice differs from guidelines and is characterized by underuse of recommended medications.
Aguilar, JC   +17 more
core   +2 more sources

Beta-blockers in COPD:time for reappraisal [PDF]

open access: yes, 2016
The combined effects on the heart of smoking and hypoxaemia may contribute to an increased cardiovascular burden in chronic obstructive pulmonary disease (COPD).
Devereux, Graham   +4 more
core   +3 more sources

Transsulfuration pathway thiols and methylated arginines: the hunter community study [PDF]

open access: yes, 2013
Background: Serum homocysteine, when studied singly, has been reported to be positively associated both with the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine [ADMA, via inhibition of dimethylarginine dimethylaminohydrolase ...
Attia, John R.   +4 more
core   +6 more sources

ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker [PDF]

open access: yes, 2016
Novel action beta-blockers combine many different pharmacological effects. The espindolol exhibits effects through β and central 5-HT1α receptors to demonstrate pro-anabolic, anti-catabolic, and appetite-stimulating actions.
Lainscak, Mitja, LAVIANO, Alessandro
core   +1 more source

Clinical Effects of Classical and Vasodilator Beta Blockers in Treating Hypertension in Adults: A Systematic Review

open access: yesJournal of Pharmacoeconomics and Pharmaceutical Management, 2021
Background: Beta-blockers are preferred anti-hypertensive for patients with compelling indications. Vasodilator beta-blockers are of particular benefit in blood pressure control and other cardio-metabolic components with limited disturbance in metabolic
Mende Mensa Sorato   +2 more
doaj  

Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh

open access: yesJournal of Family Medicine and Primary Care, 2020
Aim: Self-medication and inappropriate beta-blocker use have been commonly reported among students. This study aimed to determine the prevalence of inappropriate self-prescription of beta-blockers among medical and dental students.
Abdulelah Adnan Abukhalaf   +6 more
doaj   +1 more source

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj   +3 more sources

Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction

open access: yesBMC Cardiovascular Disorders, 2021
Background The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF) and those with reduced ejection fraction ...
Jun Shitara   +12 more
doaj   +1 more source

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

open access: yesRespiratory Research, 2017
Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective ...
Sean Duffy   +26 more
doaj   +1 more source

Home - About - Disclaimer - Privacy